STOCK TITAN

Surgalign Holdings Inc - SRGA STOCK NEWS

Welcome to our dedicated news page for Surgalign Holdings (Ticker: SRGA), a resource for investors and traders seeking the latest updates and insights on Surgalign Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Surgalign Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Surgalign Holdings's position in the market.

Rhea-AI Summary
Surgalign Holdings, Inc. announced that its securities will be delisted from the Nasdaq Stock Market due to the company's voluntary petition for relief under chapter 11 of the U.S. Bankruptcy Code. The delisting will take effect on July 3, 2023, and the company's common stock is expected to begin trading on the OTC under the symbol SRGAQ.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
38.81%
Tags
none
-
Rhea-AI Summary
Surgalign Holdings, Inc. has entered into an asset purchase agreement to sell its U.S. hardware and biomaterials assets to Xtant Medical Holdings, Inc. for $5.0 million. The sale will be effectuated through the chapter 11 proceedings initiated by the Company. The proposed sale process also includes the Company's other assets. The Company believes it has sufficient liquidity to conduct its businesses and fund the chapter 11 proceedings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-81.97%
Tags
none
-
Rhea-AI Summary
Surgalign Holdings, Inc. will be exhibiting at ISASS 2023 to showcase its upgraded HOLO Portal™ Surgical Guidance System and key products in its hardware spine and biologics portfolio.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.93%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.61%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.5%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.34%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.1%
Tags
Surgalign Holdings Inc

Nasdaq:SRGA

SRGA Rankings

SRGA Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing

About SRGA

surgalign holdings, inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. it offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; simmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and fortilink ibf system with tetrafuse ?3d technology. the company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. it markets its products through its direct distribution force and various oem relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. the company was founded in 1997 and is headquartered in dee